The Patent Finder

Daewoong Co., Ltd.

11 patents currently held · Updated Nov 15, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 5, 2027
    The maintenance fee for Medium composition for preparing botulinum toxin (US 10,465,179) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Method for Producing Botulinum Toxin (US 10,619,143) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,409,586Stable liquid formulation of human growth hormone
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,155,697Stable liquid compositions for treating stomatitis comprising epidermal growth factor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,685,440Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,918,937Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,512,418Method for production of botulinum toxin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,926,549Medium composition for preparing botulinum toxin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,308,923Medium Composition for Preparing Botulinum Toxin
In force
 · High confidence
In forceHigh confidence
US 10,465,179Medium composition for preparing botulinum toxin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,117,927Medium composition for preparing botulinum toxin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,619,143Method for Producing Botulinum Toxin
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 1 patent in force now held by others · 2 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited